Ethical Considerations in Surgical Pathology: Balancing Diagnostic Accuracy with Patient Care

Aaron Joyce^*
*Correspondence: Aaron Joyce, Department of Surgery, University of Alberta, Canada, Email:

Introduction

Ethical considerations in surgical pathology play a pivotal role in ensuring
that diagnostic practices not only provide accurate results but also prioritize
patient care. Surgical pathology is a critical component of healthcare, as
it directly influences the diagnosis, treatment and outcomes of patients.
Pathologists, as key members of the medical team, face the complex challenge
of balancing diagnostic accuracy with the ethical imperatives of patient care.
While pathologists are tasked with interpreting tissue samples, their role extends
beyond the laboratory, intertwining with the broader responsibility of ensuring
patient welfare and providing clear, actionable insights to clinicians. One of
the foremost ethical concerns in surgical pathology is ensuring the accuracy
and reliability of diagnoses. Pathologists are responsible for identifying various
diseases, including cancer, infections and inflammatory conditions, based on
histopathological examination. The accuracy of these diagnoses is crucial, as
they inform treatment decisions and can significantly affect patient outcomes.
Misdiagnoses, whether false positives or false negatives, can have devastating
consequences, leading to inappropriate treatments or missed opportunities for
effective interventions. In this context, pathologists must continuously engage
with the latest technological advancements, rigorous training and peer-review
processes to uphold diagnostic standards.
However, diagnostic accuracy is not always a straightforward pursuit. In
some cases, pathologists may encounter ambiguous or challenging cases
where clear-cut diagnoses are not possible. The ethical dilemma arises when
pathologists must communicate uncertainty in their findings. While definitive
diagnoses are ideal, medical practice often requires nuanced decision-making
when there is ambiguity. The ability to convey uncertainty in a manner that
is both transparent and respectful of patient autonomy becomes an ethical
responsibility. Pathologists must work closely with clinicians, ensuring that
they present all relevant information in a way that helps guide the patient’s
treatment journey, while being mindful of the potential emotional impact of an
uncertain diagnosis [1,2].

Description

In addition to the technical aspects of diagnosis, pathologists also have
an ethical duty to ensure patient confidentiality and privacy. Surgical pathology
often involves sensitive personal health information, which, if mishandled,
could result in a breach of trust between patients and healthcare providers.
Ethical pathologists must adhere to strict confidentiality guidelines, ensuring
that patient information is shared only with those involved in the patient’s
care. Furthermore, they must navigate the complexities of obtaining informed
consent, ensuring that patients are fully aware of the procedures involved
in tissue sampling and the potential risks. This consent process must be
conducted in a manner that respects the patient's autonomy, providing clear,
comprehensible information about the nature and purpose of the pathology

examination. Moreover, there is a growing recognition of the ethical significance of cultural competence in surgical pathology. Pathologists must be attuned to the diverse cultural backgrounds and values of the patients they serve, as these factors can influence how patients perceive medical procedures and diagnoses. In some cultures, for example, there may be strong preferences or aversions regarding tissue sampling or biopsy procedures. Pathologists, therefore, have the responsibility to engage with patients in a culturally sensitive manner, ensuring that their communication respects these values while still adhering to the standards of medical practice.

Conclusion

At times, surgical pathology may also involve dilemmas related to the use
of emerging technologies, such as artificial intelligence and machine learning,
in the diagnostic process. These technologies promise to enhance diagnostic
accuracy and efficiency, but they also raise concerns about their potential
to replace human judgment and introduce bias into the diagnostic process.
Pathologists must navigate these technologies with caution, ensuring that they
augment rather than replace the crucial role of human expertise. Additionally,
there must be safeguards in place to ensure that these technologies are not
used in ways that could harm patients, either by producing inaccurate diagnoses
or by further entrenching healthcare disparities. Ethical considerations in
surgical pathology are not merely theoretical or academic but have practical
implications for patient care. Pathologists, as guardians of diagnostic accuracy
and patient confidentiality, play an essential role in the healthcare system. By
balancing the demands of accurate diagnosis with a commitment to patientcentered
care, cultural sensitivity and justice, pathologists can contribute to
better health outcomes and foster a healthcare environment that upholds the
highest ethical standards. In doing so, they ensure that the practice of surgical
pathology remains not only a science but also a compassionate and ethical
profession that places patient welfare at the forefront.

References

<ol>
  <li><a name="1" id="1"></a>Cheng, Du, Chengliang Zhu, Fei Liao and Liang       Zhao, et al. &quot;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667091/" target="_blank">Reciprocal induction of hepatitis C virus       replication and stimulation of hepatic profibrogenic cytokine release and       cellular viability by YKL-40</a>.&quot;&nbsp;<em>Ann Transl Med</em>&nbsp;9       (2021).</li>
  <p align="right"><a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=1.%09Cheng%2C+D.%3B+Zhu%2C+C.%3B+Liao%2C+F.%3B+Zhao%2C+L.%3B+Shen%2C+L.%3B+Jiang%2C+W.+Reciprocal+induction+of+hepatitis+C+virus+replication+and+stimulation+of+hepatic+profibrogenic+cytokine+release+and+cellular+viability+by+YKL-40.+Ann.+Transl.+Med.+2021%2C+9%2C+1649&btnG=" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.21037/atm-21-4537" target="_blank"><u>Crossref</u></a>, <a href="https://pubmed.ncbi.nlm.nih.gov/34988158/" target="_blank"><u>Indexed at</u></a></p>
  <li><a name="2" id="2"></a>Li, Wenting, Xiaoqiong Duan, Chuanlong Zhu and       Xiao Liu et al. &quot;<a href="https://journals.aai.org/jimmunol/article/208/3/672/234885" target="_blank">Hepatitis B And Hepatitis C Virus Infection       Promote Liver Fibrogenesis Through A TGF-?1–Induced OCT4/Nanog pathway</a>.&quot;&nbsp;<em>J Immunol </em>208 (2022):       672-684.</li>
  <p align="right"><a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=2.%09Li%2C+W.%3B+Duan%2C+X.%3B+Zhu%2C+C.%3B+Liu%2C+X.%3B+Jeyarajan%2C+A.J.%3B+Xu%2C+M.%3B+Tu%2C+Z.%3B+Sheng%2C+Q.%3B+Chen%2C+D.%3B+Zhu%2C+C.%3B+et+al.+Hepatitis+B+and+Hepatitis+C+Virus+Infection+Promote+Liver+Fibrogenesis+through+a+TGF-%CE%B21-Induced+OCT4%2FNanog+Pathway.+J.+Immunol.+2022%2C+208%2C+672%E2%80%93684&btnG=" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.4049/jimmunol.2001453" target="_blank"><u>Crossref</u></a>, <a href="https://pubmed.ncbi.nlm.nih.gov/35022275/" target="_blank"><u>Indexed at</u></a></p>
</ol>